Healthcare Equipment and Supplies
Company Overview of Cellnovo Limited
Cellnovo Limited, a medical technology company, develops and markets mobile diabetes management systems. The company’s mobile diabetes management system includes insulin patch pumps, and activity monitors, as well as cellular enabled wireless touchscreen handsets with integrated blood glucose meters and automatic connectivity to the cloud. Its touchscreen headset device is used for monitoring blood glucose, insulin, carbohydrate intake, and intensity and timing of daily activity, as well as for automatically recording insulin, blood glucose, food, and exercise related information. The company markets its insulin patch pump systems via a direct sales force in the United Kingdom and France, as...
Swansea, SA1 8AS
Key Executives for Cellnovo Limited
Executive Chairman and Chief Executive Officer
Total Annual Compensation: $173.3K
Compensation as of Fiscal Year 2014.
Cellnovo Limited Key Developments
Cellnovo Limited Hires Senior Management Team; Opens New Subsidiary in France with an Office in Paris
Apr 22 14
Cellnovo Limited announced the appointments of three executives to the senior management team. Bart Bergstein has been appointed as Chief Financial Officer, Steve Bubrick as Vice President Global Marketing and Business Development, and Didier Moire as Area Director of newly created Cellnovo France. Bart Bergstein has a 24 year track record in the financial industry including 14 years in Venture Capital. After joining the private equity arm of ABN AMRO in 1997, Bart established the AMRO Life Sciences Team that later spun out as Forbion Capital Partners. Steve Bubrick has more than 20 years of experience in the diabetes industry. He joins Cellnovo from Asante Solutions where he held the position of Vice President Commercial Operations. Prior to Asante, Steve held senior commercial positions at Insulet, Abbott, Therasense and Lifescan where he was involved in bringing disruptive monitoring and insulin delivery products to markets worldwide. Steve will also be in charge of laying the foundations of Cellnovo's business in North America, starting with overseeing its regulatory filing process.
Recognizing the importance of the diabetes market in France, Cellnovo has created a subsidiary in the country with an office in Paris, where Didier Moire will be based and responsible for sales in France, Belgium and Luxembourg. Didier has more than 25 years' experience in Medical Technology and Diagnostics. He was previously Managing Director France/Benelux for Immucor and also held senior positions in Chiron and Novartis.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries